Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 6Recruiting 5Not yet recruiting 3Unknown 2Active not recruiting 2Suspended 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Leiomyoma 2Breast Neoplasms 2Vomiting 1Vascular Malformations 1Uterine Neoplasms 1Resectable Pancreatic Ductal Adenocarcinoma 1Prostatic Neoplasms 1Pregnancy Complications 1Postoperative Hemorrhage 1Postoperative Complications 1Neoplasms 1Nausea 1Myofibroma 1Myasthenia Gravis 1Microbiota 1Melanoma 1Lymphangioma 1Infertility, Female 1Hepatitis B 1Hand-Foot Skin Reaction (HFSR) 1Glioblastoma 1Erectile Dysfunction 1Carcinoma, Non-Small-Cell Lung 1Blood Loss, Surgical 1

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × Tablets × Clear all
NCT04389073 2022-02-25

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Unknown
138 enrolled
Breast

Breast Neoplasms

NCT03024580 2019-08-15

MEGA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
20 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡